This was achieved through the analysis and six-month follow-up of patients with type 1 diabetes mellitus who used insulin pump therapy, comparing their results with those from the same patients during a period when they were on MDI insulin therapy. This evidence concerns the gene INS and type 1 diabetes mellitus.